Q-linea AB (CHIX:QLINES) Interest Expense: kr-6.25 Mil (TTM As of Mar. 2026)


CHIX:QLINES Q-linea AB CHIX:QLINES
68 GF Score
Price kr1,610.00
GF Value kr1,981.69
! 3 Warning Signs
View Full Analysis

What is Q-linea AB Interest Expense?

Q-linea AB CHIX:QLINES 68 Interest Expense is kr-6.25 Mil as of Mar. 2026. GuruFocus rates CHIX:QLINES with a GF Score™ of 68/100 and a GF Value™ of kr1,981.69. The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Q-linea AB's interest expense for the three months ended in Mar. 2026 was kr -0.43 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was kr-6.25 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Q-linea AB's Operating Income for the three months ended in Mar. 2026 was kr -35.10 Mil. Q-linea AB's Interest Expense for the three months ended in Mar. 2026 was kr -0.43 Mil. Q-linea AB did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Q-linea AB  (CHIX:QLINEs) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Q-linea AB's Interest Expense for the three months ended in Mar. 2026 was kr-0.43 Mil. Its Operating Income for the three months ended in Mar. 2026 was kr-35.10 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was kr0.94 Mil.

Q-linea AB's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Q-linea AB did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Q-linea AB Interest Expense Historical Data

* Premium members only.

The historical data trend for Q-linea AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-linea AB Interest Expense Chart

Q-linea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.77 -0.72 -0.86 -3.11 -6.31

Q-linea AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.63 -0.85 -1.70 -3.27 -0.43
CHIX:QLINES
68GF Score
Q-linea AB CHIX:QLINES
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-linea AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-6.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of kr-6.25 Mil mean?
Q-linea AB (CHIX:QLINES) has a Interest Expense of kr-6.25 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Q-linea AB and its competitors.
Is Q-linea AB's Interest Expense too high?
Q-linea AB's current Interest Expense is kr-6.25 Mil. Overall, Q-linea AB has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Interest Expense compare to ABT and SYK?
Q-linea AB's Interest Expense of kr-6.25 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Q-linea AB and its competitors. Q-linea AB's current Interest Expense is kr-6.25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Q-linea AB (CHIX:QLINES) has a current Interest Expense of kr-6.25 Mil. The stock's GF Value™ is kr1,981.69, compared to a current price of kr1,610.00 — trading 18.8% below its estimated fair value. The current Interest Expense is kr-6.25 Mil. Q-linea AB's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Q-linea AB (CHIX:QLINES), the current Interest Expense is kr-6.25 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Q-linea AB (CHIX:QLINES) Overvalued in 2026?

Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued. The current stock price of kr1,610.00 is trading 18.8% below its estimated GF Value™ of kr1,981.69.

Key valuation signals for CHIX:QLINES:

  • Interest Expense: kr-6.25 Mil
  • GF Value™: kr1,981.69 vs. price of kr1,610.00 (18.8% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the CHIX:QLINES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Q-linea AB Business Description

Other Exchanges QLINEA:Sweden3F80:Germany
Address Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
68GF Score

Get the complete analysis for CHIX:QLINES

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1,610.00
Price
kr1,981.69
GF Value